KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Equity Average (2016 - 2025)

Historic Equity Average for West Pharmaceutical Services (WST) over the last 16 years, with Q3 2025 value amounting to $3.0 billion.

  • West Pharmaceutical Services' Equity Average rose 1222.95% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 1222.95%. This contributed to the annual value of $2.8 billion for FY2024, which is 4.67% down from last year.
  • West Pharmaceutical Services' Equity Average amounted to $3.0 billion in Q3 2025, which was up 1222.95% from $2.8 billion recorded in Q2 2025.
  • West Pharmaceutical Services' Equity Average's 5-year high stood at $3.0 billion during Q3 2025, with a 5-year trough of $1.8 billion in Q1 2021.
  • For the 5-year period, West Pharmaceutical Services' Equity Average averaged around $2.5 billion, with its median value being $2.7 billion (2024).
  • Per our database at Business Quant, West Pharmaceutical Services' Equity Average skyrocketed by 2735.78% in 2021 and then plummeted by 547.55% in 2024.
  • West Pharmaceutical Services' Equity Average (Quarter) stood at $2.3 billion in 2021, then rose by 13.62% to $2.6 billion in 2022, then rose by 11.51% to $2.9 billion in 2023, then dropped by 5.48% to $2.7 billion in 2024, then rose by 10.05% to $3.0 billion in 2025.
  • Its Equity Average stands at $3.0 billion for Q3 2025, versus $2.8 billion for Q2 2025 and $2.7 billion for Q1 2025.